Mihail Obrocea - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role: Chief Medical Officer
Signature: /s/ Mihail Obrocea
Issuer symbol: MAIA
Transactions as of: 27 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 27 Jul 2022, 18:32:15 UTC
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MAIA	Common Stock						26,100	27 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MAIA	Options							27 Jul 2022	Common Stock	13,269	$1.80	Direct	F2
holding	MAIA	Options							27 Jul 2022	Common Stock	6,131	$1.80	Direct	F2
holding	MAIA	Options							27 Jul 2022	Common Stock	10,022	$1.83	Direct	F2
holding	MAIA	Options							27 Jul 2022	Common Stock	7,447	$1.83	Direct	F3
holding	MAIA	Options							27 Jul 2022	Common Stock	6,476	$1.83	Direct	F4
holding	MAIA	Options							27 Jul 2022	Common Stock	260,000	$1.83	Direct	F5
holding	MAIA	Option							27 Jul 2022	Common Stock	7,436	$1.83	Direct	F6
holding	MAIA	Options							27 Jul 2022	Common Stock	772	$8.00	Direct	F7
holding	MAIA	Warrants							27 Jul 2022	Common Stock	8,820	$6.00	Direct	F8
holding	MAIA	Warrants							27 Jul 2022	Common Stock	4,230	$6.00	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Obrocea beneficially owns 26,100 shares of common stock.
F2	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 11, 2021.
F3	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 7, 2021.
F4	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 5, 2021.
F5	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. 25% of these options vest in 1 year with the remaining options vesting in 36 equal monthly installments beginning on July 15, 2021.
F6	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on June 30, 2021.
F7	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on July 31, 2021.
F8	Each Warrant became exercisable on the date of issuance of October 10, 2020, and expire on the earliest to occur of: (a) October 10, 2027 or (b) immediately prior to the closing of any change of control of the issuer.
F9	Each Warrant became exercisable on the date of issuance of June 29, 2021, and expire on the earliest to occur of: (a) June 28, 2028 or (b) immediately prior to the closing of any change of control of the issuer.